Dapagliflozin attenuates diabetic renal fibrosis by inhibiting macrophage-myofibroblast transition via the TGF-β1-Smad3/7 pathway

Objective Renal fibrosis plays a pivotal role in the progression of renal dysfunction in diabetic kidney disease (DKD), with the macrophage-to-myofibroblast transition (MMT) serving as a central mechanism driving the advancement of renal fibrosis to end-stage renal disease (ESRD) in various chronic...

詳細記述

書誌詳細

主要な著者:	Xiaoyun Li, Guoxiang Yao, Honggang Wang, Tingting Zhao, Yujiao Sun, Qi Gao, Zhuo Li, Bing Chen
フォーマット:	Artigo
言語:	Inglês
出版事項:	PeerJ Inc. 2026-06-01
シリーズ:	PeerJ
主題:	Diabetic kidney disease Dapagliflozin Renal fibrosis Macrophage-myofibroblast transition (MMT) TGF-β1/Smad
オンライン･アクセス:	https://peerj.com/articles/21321.pdf
タグ:	タグ追加 タグなし, このレコードへの初めてのタグを付けませんか!